UTime Limited (WTO)
NASDAQ: WTO · Real-Time Price · USD
1.100
-0.050 (-4.35%)
At close: Aug 8, 2025, 4:00 PM
1.080
-0.020 (-1.82%)
After-hours: Aug 8, 2025, 5:15 PM EDT
UTime Revenue
UTime had revenue of 138.41M CNY in the half year ending September 30, 2024, with 8.39% growth. This brings the company's revenue in the last twelve months to 226.64M, up 47.36% year-over-year. In the fiscal year ending March 31, 2024, UTime had annual revenue of 172.16M, down -12.86%.
Revenue (ttm)
226.64M CNY
Revenue Growth
+47.36%
P/S Ratio
0.00
Revenue / Employee
1,317,645 CNY
Employees
172
Market Cap
23.04M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 172.16M | -25.41M | -12.86% |
| Mar 31, 2023 | 197.56M | -77.94M | -28.29% |
| Mar 31, 2022 | 275.51M | 28.61M | 11.59% |
| Mar 31, 2021 | 246.90M | 53.81M | 27.87% |
| Mar 31, 2020 | 193.09M | -45.01M | -18.90% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apple | 408.63B |
| Microsoft | 281.72B |
| NVIDIA | 148.52B |
| Taiwan Semiconductor Manufacturing Company | 116.30B |
| Oracle | 57.40B |
| Broadcom | 57.05B |
| Cisco Systems | 55.62B |
| SAP SE | 42.15B |
WTO News
- 4 months ago - UTime Limited Announces 1-For-10 Reverse Share Split - GlobeNewsWire
- 10 months ago - UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency - GlobeNewsWire
- 11 months ago - UTime Limited Announces Pricing of $5 Million Registered Direct Offering - GlobeNewsWire
- 11 months ago - UTime Limited Announces 1-For-25 Reverse Share Split - GlobeNewsWire
- 1 year ago - Remarkable Announcement on Significant Fluctuation of the UTime's Share Price - PRNewsWire
- 1 year ago - UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics - PRNewsWire
- 1 year ago - UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines - PRNewsWire
- 1 year ago - About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron - PRNewsWire